share_log

MiNK Therapeutics Q4 EPS $(0.16) Misses $(0.15) Estimate

Moomoo 24/7 ·  Mar 21 07:06

MiNK Therapeutics (NASDAQ:INKT) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 30.43 percent increase over losses of $(0.23) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment